Europe · Wires & real time · Reuters

Novo loses share in Brazil to cheaper generics, but holds up in Canada and India

Published by Reuters · United Kingdom 13 h ago

Novo ‌Nordisk is losing market share in Brazil after its semaglutide patent expired, driving a 3% decline in emerging market sales in the third quarter, CEO Mike Doustdar told…

Read the full article on Reuters Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

TASS

Houthis claim ballistic missile strike on Riyadh airport

Anadolu Agency

Brent crude falls below $100 a barrel for first time in month as European gas prices drop

Reuters Europe Markets

Novo loses share in Brazil to cheaper generics, but holds up in Canada and India

Share

Also worth reading

Houthis claim ballistic missile strike on Riyadh airport

Brent crude falls below $100 a barrel for first time in month as European gas prices drop

European lawmakers push to weaken car CO2 emissions targets

Elon Musk and Donald Trump: dynamic antigraft duo

Sublime Musetti stuns world number one Zverev at Paris Masters

TAILG Showcases Long-Range Technology and a Versatile Product Lineup at EICMA 2026